华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301267 华厦眼科

已收盘 07-25 15:00:00

{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":20.35,"timestamp":1753426986000,"preClose":20.53,"halted":0,"volume":8041404,"delay":0,"changeRate":-0.0088,"floatShares":329000000,"shares":840000000,"eps":0.5029,"marketStatus":"已收盘","change":-0.18,"latestTime":"07-25 15:00:00","open":20.46,"high":20.68,"low":20.26,"amount":164000000,"amplitude":0.0205,"askPrice":20.36,"askSize":40,"bidPrice":20.35,"bidSize":147,"shortable":0,"etf":0,"ttmEps":0.5029,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.53,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":22.58,"lowLimit":18.48,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.92,"roa":"--","peRate":40.465301,"roe":"2.55%","epsLYR":0.51,"committee":0.298077,"marketValue":17094000000,"turnoverRate":0.0245,"status":1,"floatMarketCap":6692000000},"requestUrl":"/m/hq/s/301267","defaultTab":"news","newsList":[{"id":"2550572505","title":"华厦眼科：密切关注眼科医疗行业相关新技术的发展和应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2550572505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550572505?lang=zh_cn&edition=full","pubTime":"2025-07-09 08:36","pubTimestamp":1752021385,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科07月08日在投资者关系平台上答复投资者关心的问题。另，公司是否已关注到脑机接口与眼科医疗领域相关方面的发展动向？同时，公司始终密切关注眼科医疗行业相关新技术的发展和应用，不断引进行业先进设备与诊疗技术、加强研发投入，致力于提供优质、前沿的诊疗服务。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900005790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2546763827","title":"华厦眼科：已与部分智能眼镜生产企业合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2546763827","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546763827?lang=zh_cn&edition=full","pubTime":"2025-06-27 08:52","pubTimestamp":1750985550,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2546876385","title":"华厦眼科：已与部分智能眼镜生产企业合作开展智能眼镜验配","url":"https://stock-news.laohu8.com/highlight/detail?id=2546876385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546876385?lang=zh_cn&edition=full","pubTime":"2025-06-27 08:45","pubTimestamp":1750985114,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科06月26日在投资者关系平台上答复投资者关心的问题。目前，公司已与部分智能眼镜生产企业合作，开展智能眼镜验配，进一步挖掘智能眼镜在眼科医疗服务领域的应用潜力。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700007738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2545287751","title":"华厦眼科：持续强化核心竞争力推动高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287751","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545287751?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:55","pubTimestamp":1750769735,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科06月23日在投资者关系平台上答复投资者关心的问题。请结合公司发展实际给予回复，谢谢华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。展望未来，华厦眼科将持续强化核心竞争力，不断提升经营效率和盈利能力，推动公司高质量发展，并持续做好市值管理工作，持续加大现金分红力度，切实增强股东回报，努力实现公司内在价值与市值的动态平衡。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400037129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2543749645","title":"全国爱眼月 | 华厦眼科领衔启动首次跨界活动，携手公益伙伴守护3.6亿干眼人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2543749645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543749645?lang=zh_cn&edition=full","pubTime":"2025-06-13 13:40","pubTimestamp":1749793214,"startTime":"0","endTime":"0","summary":"正值全国爱眼月期间，华厦眼科医院集团联合上海大学、挪瓦咖啡、上海新奥光明公益基金会联合举办“眼健康干眼润目公益活动暨科技创新平台发布仪式”，发布全国首个干眼AI自测工具，启动“眼科技术联合转化中心”项目，以“公益创新+科技赋能+健康饮品”创新理念为国民眼健康筑起坚实的立体防线。他表示，华厦眼科将结合优势专业医疗服务，进一步推动眼科AI智能筛查技术的广泛应用，用公益普惠的方式，让科技为眼健康保驾护航。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025061300016343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2535356842","title":"华厦眼科：5月15日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2535356842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535356842?lang=zh_cn&edition=full","pubTime":"2025-05-15 20:07","pubTimestamp":1747310867,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年5月15日华厦眼科发布公告称公司于2025年5月15日召开业绩说明会。感谢您对华厦眼科的关注和支持。华厦眼科2025年一季报显示，公司主营收入10.93亿元，同比上升11.74%；归母净利润1.5亿元，同比下降4.0%；扣非净利润1.4亿元，同比下降11.12%；负债率24.03%，投资收益750.88万元，财务费用1090.24万元，毛利率44.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051500033039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2535030074","title":"华厦眼科：公司在提供医疗服务过程中严格执行国家税收相关的法律法规","url":"https://stock-news.laohu8.com/highlight/detail?id=2535030074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535030074?lang=zh_cn&edition=full","pubTime":"2025-05-14 08:48","pubTimestamp":1747183699,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科(301267)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司眼科医院提供的医疗服务过程中所销售药品是否缴纳增值税华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。公司在提供医疗服务过程中严格执行国家税收相关的法律法规。再次感谢您对华厦眼科的支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400006747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2534483222","title":"东海证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2534483222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534483222?lang=zh_cn&edition=full","pubTime":"2025-05-09 19:50","pubTimestamp":1746791433,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏,伍可心近期对华厦眼科进行研究并发布了研究报告《公司简评报告：业绩短期承压，消费眼科稳健增长》，给予华厦眼科买入评级。　　华厦眼科　　投资要点　　2024年业绩承压，2025Q1环比改善。预计该举措将形成有效激励，充分调动核心管理人员和技术骨干的积极性。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有12家机构给出评级，买入评级11家，增持评级1家；过去90天内机构目标均价为23.69。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900035320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","161027"],"gpt_icon":0},{"id":"2531274867","title":"【机构调研记录】合煦智远基金调研华厦眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2531274867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531274867?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:06","pubTimestamp":1745971585,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月29日披露的机构调研信息，合煦智远基金近期对1家上市公司进行了调研，相关名单如下：1）华厦眼科 调研纪要：2024年度，华厦眼科实现营业收入40.27亿元，同比增长0.35%，净利润4.29亿元，同比下降35.63%。旗下最近一年表现最佳的公募基金产品为金融科技LOF，最新单位净值为1.02，近一年增长25.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000011050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2531717914","title":"东吴证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531717914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531717914?lang=zh_cn&edition=full","pubTime":"2025-04-30 07:32","pubTimestamp":1745969571,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对华厦眼科进行研究并发布了研究报告《2024年年报及2025一季报点评：24年消费眼科稳健增长，战略收购持续推进》，给予华厦眼科买入评级。　　2024年屈光及视光稳健增长，白内障收入承压。我们预计随着消费需求进一步释放，眼科医疗行业依然具备良好的发展空间，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家；过去90天内机构目标均价为24.88。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000010145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","301267"],"gpt_icon":0},{"id":"2531029866","title":"华厦眼科（301267）2025年一季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2531029866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531029866?lang=zh_cn&edition=full","pubTime":"2025-04-29 06:20","pubTimestamp":1745878831,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华厦眼科发布2025年一季报。截至本报告期末，公司营业总收入10.93亿元，同比上升11.74%，归母净利润1.5亿元，同比下降4.0%。本报告期华厦眼科公司应收账款体量较大，当期应收账款占最新年报归母净利润比达76.43%。去年的净利率为10.63%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900006906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2530143887","title":"华厦眼科(301267)3月31日股东户数2.1万户，较上期增加10.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530143887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530143887?lang=zh_cn&edition=full","pubTime":"2025-04-27 17:14","pubTimestamp":1745745245,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华厦眼科披露，截至2025年3月31日公司股东户数为2.1万户，较12月31日增加1961.0户，增幅为10.31%。在医疗服务行业个股中，华厦眼科股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.46万户。从股价来看，2024年12月31日至2025年3月31日，华厦眼科区间涨幅为4.67%，在此期间股东户数增加1961.0户，增幅为10.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700007402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2530874804","title":"图解华厦眼科年报：第四季度单季净利润同比减92.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530874804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530874804?lang=zh_cn&edition=full","pubTime":"2025-04-27 16:44","pubTimestamp":1745743481,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科2024年年报显示，公司主营收入40.27亿元，同比上升0.34%；归母净利润4.29亿元，同比下降35.63%；扣非净利润4.09亿元，同比下降38.29%；其中2024年第四季度，公司单季度主营收入8.45亿元，同比下降7.16%；单季度归母净利润777.92万元，同比下降92.83%；单季度扣非净利润-777.79万元，同比下降108.65%；负债率23.99%，投资收益7084.91万元，财务费用3506.51万元，毛利率44.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700006464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"gpt_icon":0},{"id":"2516645761","title":"华厦眼科：有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2516645761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516645761?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:30","pubTimestamp":1741073438,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月04日在投资者关系平台上答复投资者关心的问题。有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告。若有进一步信息，公司将及时履行信披义务。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400020849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2514406433","title":"华厦眼科收盘下跌1.22%，滚动市盈率29.67倍，总市值157.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406433","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514406433?lang=zh_cn&edition=full","pubTime":"2025-02-25 18:41","pubTimestamp":1740480063,"startTime":"0","endTime":"0","summary":"2月25日，华厦眼科今日收盘18.7元，下跌1.22%，滚动市盈率PE达到29.67倍，总市值157.08亿元。从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均48.80倍，行业中值45.66倍，华厦眼科排名第21位。截至2024年三季报，共有2家机构持仓华厦眼科，其中基金2家，合计持股数4.21万股，持股市值0.01亿元。华厦眼科医院集团股份有限公司主营业务为眼科医疗服务，向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25184148377123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2512122492","title":"华厦眼科：请您提供持股证明致电或发送邮件至公司证券部查询","url":"https://stock-news.laohu8.com/highlight/detail?id=2512122492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512122492?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:30","pubTimestamp":1739950228,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科(301267)02月19日在投资者关系平台上答复投资者关心的问题。投资者：请问贵公司2025年02月17日收盘股东人数是多少华厦眼科董秘：尊敬的投资者您好，感谢您对华厦眼科的关注。请您提供持股证明致电或发送邮件至公司证券部查询。再次感谢您对华厦眼科的支持！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900021050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2512312391","title":"华厦眼科跌3.39% 2022年上市超募19.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512312391","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512312391?lang=zh_cn&edition=full","pubTime":"2025-02-18 16:18","pubTimestamp":1739866680,"startTime":"0","endTime":"0","summary":"中国经济网北京2月18日讯华厦眼科今日收报18.52元，跌幅3.39%，总市值155.57亿元。　　华厦眼科首次公开发行募集资金总额为305,280.00万元，扣除发行费用后，募集资金净额为276,849.25万元。华厦眼科最终募集资金比原计划多198998.64万元。　　华厦眼科的发行费用为28,430.75万元，其中保荐及承销费用为23,201.28万元。　　2023年7月4日，华厦眼科披露2022年年度权益分派实施公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-02-18/doc-inekwyyz7022104.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-18/doc-inekwyyz7022104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2503602546","title":"【机构调研记录】鹏扬基金调研华厦眼科、汉威科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2503602546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503602546?lang=zh_cn&edition=full","pubTime":"2025-01-16 08:03","pubTimestamp":1736985811,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及1月15日披露的机构调研信息，鹏扬基金近期对2家上市公司进行了调研，相关名单如下：1）华厦眼科 个股亮点：公司的眼科医疗业务主要包括白内障、屈光、眼底、眼表、斜弱视及小儿眼科及其他项目。旗下最近一年表现最佳的公募基金产品为鹏扬中证数字经济主题ETF，最新单位净值为0.76，近一年增长39.62%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011600006407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0026","BK0130","BK0058","BK0077","BK0121","BK0070","BK0150","BK0162","BK0067","BK0236","300007","BK0225"],"gpt_icon":0},{"id":"2503602528","title":"【机构调研记录】华泰柏瑞基金调研华厦眼科、汉威科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2503602528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503602528?lang=zh_cn&edition=full","pubTime":"2025-01-16 08:02","pubTimestamp":1736985752,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及1月15日披露的机构调研信息，华泰柏瑞基金近期对2家上市公司进行了调研，相关名单如下：1）华厦眼科 个股亮点：公司的眼科医疗业务主要包括白内障、屈光、眼底、眼表、斜弱视及小儿眼科及其他项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011600006352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","BK0225","BK0162","301267","BK0236","BK0150","BK0026","BK0067","BK0121","300007","BK0058","BK0130"],"gpt_icon":0},{"id":"2503865473","title":"华厦眼科：有知名机构正心谷资本，高毅资产参与的多家机构于1月14日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2503865473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503865473?lang=zh_cn&edition=full","pubTime":"2025-01-15 11:31","pubTimestamp":1736911886,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年1月15日华厦眼科发布公告称高毅资产冯鹏、华泰柏瑞基金邹丽晴、PAG李沄、鹏扬基金王雪刚、东方红资管邹秉昂、正心谷资本余梦珂、云阳宜品刘江山、中金公司张一弛 李千翊于2025年1月14日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011500016734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753585263077,"stockEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":0.0719},{"period":"3month","weight":0.0843},{"period":"6month","weight":0.1607},{"period":"1year","weight":0.0849},{"period":"ytd","weight":0.0809}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"20981人(较上一季度增加10.31%)","perCapita":"15672股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":"　　华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}